Product finder
CD1c (BDCA-1)+ Dendritic Cell Isolation Kit, human
Everything you need for the isolation of CD1c+ DCs from human PBMCs, now, with optional depletion of CD14+ myeloid cells.
March 1, 2018
CD45 (TIL) MicroBeads, human
Optimized for the isolation of TILs from human tumors and xenotransplanted tumors with a humanized immune system.
March 1, 2018
StemMACS™ Small Molecules
Find out more about our growing range of small molecule activators and inhibitors here.
January 1, 2018

REAlease MicroBead Kits, human

Maximal flexibility with our releasable MicroBeads and antibody fragments for positive cell isolation from PBMCs.

December 2, 2017

MolMed and Miltenyi Biotec: EMA approves the utilization of the CliniMACS Prodigy® equipment

MolMed and Miltenyi Biotec: EMA approves the utilization of the CliniMACS Prodigy® equipment in the commercial manufacturing process of Zalmoxis®, a patient-specific cell therapy for the treatment of adult patients affected by leukemia and other high-risk hematological malignancies.

March 1, 2018

Cancer coaching for the immune system

Novel cell therapy will teach immune cells how to fight cancer

February 1, 2018

Krebs Nachhilfe für das Immunsystem

Neuartige Zelltherapie soll Immunzellen in der Krebsabwehr schulen

February 1, 2018
Cell separation – faster and more reliable than ever

New: The MultiMACS™ X raises fully automated, walk-away, high-throughput cell separation to a new level

November 2, 2017
E-ISFA 2nd Congress of the European Group
Vienna, Austria - March 22-24
Munich, Germany - April 10-13
AACR - Annual Meeting American Association for Cancer Research
Chicago, IL, USA - April 14-18
ASFA - Annual Meeting American Society for Apheresis
Chicago, IL, USA - April 25-28

Customer login


Forgot password?
Register for account

0 Shopping cart


Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
Contact overview

Product finder

Antibody panel builder


EBMT 2018 Symposium

EBMT 2018 Symposium

Change country

Please select your country to continue